Cyted Acquires Digital Pathology, Clinical Lab Services Provider Pathognomics
Cyted Acquires Digital Pathology, Clinical Lab Services Provider Pathognomics

Cyted, a developer and provider of artificial intelligence technology and digital diagnostic infrastructure to enable earlier detection of disease, has acquired Pathognomics, a provider of digital pathology and clinical diagnostic laboratory services, based in Huntingdon.

The acquisition of Pathognomics will provide Cyted an accredited laboratory environment and digital pathology technology, enabling the uptake and expansion of the pipeline of biomarkers and artificial intelligence (AI) technology at Cyted.

Marcel Gehrung, CEO, Cyted, said: “We are delighted to expand our team with the acquisition of Pathognomics. We have seen great synergy in our work and values through our partnership to launch and deliver our integrated diagnostic service. Merging the two companies is the next step in fulfilling our vision at Cyted, to change lives by enabling earlier disease detection and diagnosis.”  

Cyted and Pathognomics have already worked together to set up and launch diagnostic services for the earlier detection of oesophageal cancer. Cyted and Pathognomics will now look to scale their combined diagnostic reporting services and infrastructure to further support both existing and future healthcare partners.

All Pathognomics employees will now join the Cyted group. Pathognomics’ co-founder and laboratory director Christopher Evagora will become Cyted’s senior director of laboratory operations, and Alec Hirst, co-founder and project director will become Cyted’s senior director of business technology. Cyted will remain headquartered in Cambridge whilst laboratory operations will continue in Huntingdon.  

Christopher Evagora, senior director of laboratory operations, Cyted, said: “From our first conversations with Cyted, it was clear that the diagnostic technology and infrastructure being developed by the team will bring significant benefit to patient care. Over the past four years, we have established and optimised our workflow here at Pathognomics. I look forward to expanding the scope of our services to the next level with the formal merging of the two companies.”

Related: New daytime sleep training device launched